PMS2 and cancer: Mismatch instances may be high in some cancers, especially those with higher tumor mutational burden owing to loss of mismatch repair (microsatellite instable-high cancers with loss of mismatch repair proteins MSH2, MSH6, MLH1, and PMS2) or loss of POLE (58, 59, 60).